Brind.

Wall Street analysts set price targets and positive earnings estimate revisions for Exact Sciences, suggesting potential stock upside.

1 report, 1 independent Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Wall Street analysts set price targets and positive earnings estimate revisions for Exact Sciences, suggesting potential stock upside.

Who's involved

What this event is mainly about
Exact Sciences

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksWall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet Exact Sciences (EXAS) closed the last trading session at $54.3, gaining 1.9% over the past four wee